Cardio-TriTest vs Strain AI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cardio-TriTest

by Cardio-Phoenix

Strain AI

by Exo

AI Verdict

Cardio-TriTest is a multi-modal diagnostic device that combines ECG, PCG, and MCG to provide a comprehensive view of heart bio-signals for general cardiovascular disease detection. Strain AI, conversely, is an AI software that analyzes cardiac ultrasound images to specifically measure Global Longitudinal Strain, aiding in the assessment of heart function and conditions like heart failure. While both serve cardiology, Cardio-TriTest focuses on direct physiological signal acquisition, whereas Strain AI enhances existing ultrasound imaging for specific functional metrics.

Choose Cardio-TriTest if…

Choose Cardio-TriTest if your primary care setting requires a comprehensive, multi-modal screening device for early and broad cardiovascular disease detection. This 3-in-1 system synchronizes and visually correlates ECG, PCG, and MCG bio-signals, offering a holistic initial assessment for a wide range of cardiac conditions.

View Cardio-TriTest →

Choose Strain AI if…

Choose Strain AI if your specialty clinic (cardiology, oncology, radiology) needs to precisely quantify myocardial function and detect subtle changes indicative of heart failure or cardiotoxicity using cardiac ultrasound images. This AI-powered software provides objective Global Longitudinal Strain (GLS) measurements, integrating with existing ultrasound workflows for enhanced diagnostic accuracy and patient monitoring.

View Strain AI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cardio-TriTest	Strain AI
Pricing	Unknown	Contact for pricing
Deployment	On-premise (device)	On-device AI, operates without internet connection.
BAA Available	Unknown	Yes AI-estimated
FDA Status	Unknown	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Strain AI

Strain AI integrates with existing ultrasound devices and offers real-time, on-device AI insights, streamlining the workflow for physicians by reducing manual image interpretation. Its accompanying Exo Works software further enhances usability with features for documentation, billing, and QA, making it highly adaptable to current clinical practices.

Clinical Value

Cardio-TriTest

Cardio-TriTest offers a broader, multi-modal diagnostic approach by combining ECG, PCG, and MCG for comprehensive cardiovascular disease detection, including structural heart disease and various heart failure phenotypes. Its clinical validation demonstrates a significant reduction in inconclusive ECGs and high agreement with echocardiography, providing a more holistic initial assessment in primary care.

Pricing & Value

Strain AI

While both require contacting for pricing, Strain AI is a software solution that integrates with existing ultrasound devices, potentially offering a lower barrier to entry and more flexible cost structure compared to a dedicated hardware device. Exo's broader ecosystem, including workflow software and enterprise solutions, suggests greater long-term value through enhanced efficiency and potential for revenue capture.

Enterprise Readiness

Strain AI

Strain AI demonstrates superior enterprise readiness with its on-device AI that operates without an internet connection, enhancing data security and reliability. Its Exo Works Enterprise solution offers comprehensive features for health systems, including robust EHR/PACS integration and certifications with major platforms like Epic and Cerner.

Innovation

Tie

Both tools exhibit significant innovation. Cardio-TriTest's 3-in-1 synchronized bio-signal acquisition for comprehensive primary care diagnostics is a novel multi-modal approach. Strain AI's real-time, on-device AI for Global Longitudinal Strain (GLS) measurement, particularly as the first handheld ultrasound with this capability, represents a substantial advancement in point-of-care imaging.

Support & Docs

Strain AI

Exo provides a more comprehensive support infrastructure, including a dedicated support center with user manuals, release notes, and multiple channels for assistance such as email, phone, and ticket submission. This level of documented support and accessibility surpasses the general contact information available for Cardio-TriTest.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cardio-TriTest	Strain AI
Name	Cardio-TriTest	Strain AI
Company	Cardio-Phoenix Inc.	Exo
Description	AI-powered 3-in-1 diagnostic device combining ECG, PCG, and MCG to synchronize and visually correlate heart bio-signals for earlier and more comprehensive cardiovascular disease detection in primary care.	AI-powered medical software that analyzes cardiac ultrasound images to measure Global Longitudinal Strain (GLS), aiding physicians in assessing heart function and detecting conditions like heart failure and cardiotoxicity in adult patients.
Key Features	3-in-1 diagnostic device (ECG, PCG, MCG), 12-Lead Electrocardiograph (ECG), 4 Lead Phonocardiograph (PCG), 4 Lead Mechanocardiograph (MCG), Synchronized bio-signal acquisition, Visual correlation of heart bio-signals, AI-powered analysis for heart disease detection, Non-invasive test procedure	Analyzes cardiac ultrasound images, Measures Global Longitudinal Strain (GLS), Aids in assessing heart function in adult patients, Integrates with existing ultrasound devices, Provides quantitative strain measurements, Supports diagnostic evaluation without manual image interpretation, Delivers real-time, on-device AI insights, Assists in detecting heart failure (CHF, HFpEF, HFrEF) and hypertrophy
Specialties	Cardiology, Family Medicine, Internal Medicine	Cardiology, Oncology, Radiology

Videos

Demos, reviews, and walkthroughs featuring Cardio-TriTest and Strain AI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate with existing EHR systems and current clinical workflows for data transfer and reporting?

Cardio-TriTest is a device that acquires synchronized ECG, PCG, and MCG bio-signals, which would then need a defined pathway for data transfer and reporting into an EHR. The visual correlation and AI analysis results would be key data points for integration. Strain AI integrates with existing ultrasound devices to analyze cardiac images and measure GLS, providing quantitative results that would need to be transferred from the ultrasound device or its associated system into the EHR for comprehensive patient records.

What specific clinical evidence or performance metrics are available regarding the accuracy and sensitivity of each tool's AI analysis for detecting cardiovascular conditions?

Cardio-TriTest uses AI-powered analysis for earlier and more comprehensive cardiovascular disease detection by correlating ECG, PCG, and MCG bio-signals. Specific clinical evidence regarding its accuracy and sensitivity would be crucial for understanding its diagnostic performance. Strain AI is designed to measure Global Longitudinal Strain (GLS) from cardiac ultrasound images to aid in assessing heart function and detecting conditions like heart failure and cardiotoxicity. Physicians would need to review the clinical validation and performance metrics for its AI-driven GLS measurements, which has shown strong correlation with traditional methods.

Given their distinct diagnostic approaches, in which specific clinical scenarios or patient populations would each tool provide the most significant diagnostic advantage?

Cardio-TriTest, with its 3-in-1 bio-signal analysis (ECG, PCG, MCG), appears well-suited for primary care settings aiming for earlier and more comprehensive cardiovascular disease detection in adult patients. It could be particularly advantageous for initial screenings or when a multi-modal, non-invasive assessment is desired. Strain AI, by analyzing cardiac ultrasound images for GLS, offers a significant advantage in assessing heart function and detecting conditions like heart failure and cardiotoxicity in adult patients, especially in cardiology, oncology, and radiology settings where ultrasound imaging is routinely performed.

What is the typical learning curve for physicians and clinical staff to effectively utilize each tool, and what is the estimated time-to-value for incorporating them into practice?

As a new 3-in-1 diagnostic device, the learning curve for Cardio-TriTest would involve familiarization with its synchronized bio-signal acquisition and visual correlation features, along with interpreting its AI-powered analysis. For Strain AI, which integrates with existing ultrasound devices, the learning curve would primarily focus on understanding the AI's GLS measurements and how to incorporate these quantitative insights into diagnostic evaluations. The time-to-value for AI tools can vary, with initial results sometimes appearing within 30-60 days for individual productivity gains, while full strategic ROI may take 12-18 months for comprehensive implementation.

What are the key considerations and support mechanisms for implementing and scaling these tools across multiple clinical sites or a larger healthcare system?

For Cardio-TriTest, multi-site rollout would involve procurement and deployment of multiple physical devices, standardized training for staff across sites on its 3-in-1 diagnostic process, and ensuring consistent data integration with various EHR instances. Scaling Strain AI across multiple sites would focus on its integration with the existing ultrasound fleet at each location, ensuring consistent software deployment and updates, and providing uniform training on GLS measurement interpretation. Multi-site deployments require careful planning to standardize processes and maintain scientific integrity across different personnel and clinical practices.